window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Digital shift aims to fix long-term gaps in cell and gene therapy trials

    Medable unveils a patient-first remote model to support 15-year safety [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    BioIVT and Handok Biotech form exclusive partnership to support research innovation in South Korea

    BioIVT, a global provider of biospecimen solutions for drug and [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Poolbeg receives FDA Orphan Drug Designation for POLB 001

    Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Alchemab strikes $415m licensing deal with Lilly for ALS candidate ATLX-1282

    UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Why rare disease trials are poised to transform drug development by 2030

    Today on Clinical Trials Day, we spotlight the evolving landscape [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Abzena forms Scientific Advisory Board to guide innovation in complex biologics

    Abzena, an integrated CDMO and CRO specializing in complex biologics [...]

    May 5, 2026
  • Advanced Therapies

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 5, 2026
Previous262728Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Medicus files IND for genomics-enabled Phase 2 endometriosis trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Vertex reports positive CASGEVY data in children and completes UK submission
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Poolbeg presents preclinical POLB 001 data at EHA Congress
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top